19728-76-8 Usage
Uses
Used in Pharmaceutical Industry:
3-Ethoxycarbonylquinolizidine is used as a pharmaceutical candidate for its potential therapeutic applications due to its biological activities. The presence of the ethoxycarbonyl group enhances its properties, making it a promising substance for further research and development in drug discovery and medicinal chemistry.
Used in Antitumor Applications:
In the field of oncology, 3-Ethoxycarbonylquinolizidine is utilized as an antitumor agent, leveraging its inherent biological activities to target and potentially inhibit the growth of cancer cells. Its structure and the ethoxycarbonyl group may contribute to its effectiveness in combating tumor development.
Used in Anti-Inflammatory Applications:
3-Ethoxycarbonylquinolizidine is also used as an anti-inflammatory agent, where its quinolizidine alkaloid properties can help in reducing inflammation and associated symptoms, offering a potential treatment option for various inflammatory conditions.
Used in Antimicrobial Applications:
Furthermore, 3-Ethoxycarbonylquinolizidine is employed as an antimicrobial agent, capitalizing on its ability to combat microbial infections. This makes it a candidate for the development of new antibiotics or antifungal agents to address the growing need for effective treatments against drug-resistant pathogens.
Check Digit Verification of cas no
The CAS Registry Mumber 19728-76-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,2 and 8 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 19728-76:
(7*1)+(6*9)+(5*7)+(4*2)+(3*8)+(2*7)+(1*6)=148
148 % 10 = 8
So 19728-76-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO2/c1-2-15-12(14)10-6-7-11-5-3-4-8-13(11)9-10/h10-11H,2-9H2,1H3
19728-76-8Relevant academic research and scientific papers
Azabicyclic indole esters as potent 5-HT4 receptor antagonists
Wyman, Paul A.,Gaster, Laramie M.,King, Frank D.,Sutton, Jonathon M.,Ellis, Elizabeth S.,Wardle, Kay A.,Young, Timothy J.
, p. 255 - 261 (2007/10/03)
The synthesis of a series of azabicyclic indole esters is described and their potency reported as 5-HT4 receptor antagonists. Optimization of the most potent compound (19) by preparing the corresponding oxazino[3,2-a]indole ester afforded 34, which had a pIC50 of 9.5 in the guinea pig distal colon longitudinal muscle myenteric plexus preparation.
